{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:23:10Z","timestamp":1790860990136,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the most common form of movement disorder and affects approximately 4% of the population aged over 80 years old. Currently, PD cannot be prevented or cured, and no single diagnostic biomarkers are available. Notably, recent studies suggest that two familial PD-linked molecules, \u03b1-synuclein and DJ-1, are present in cerebrospinal fluid (CSF) and that their levels may be altered during the progression of PD. In this regard, sensitive and accurate methods for evaluation of \u03b1-synuclein and DJ-1 levels in the CSF and blood have been developed, and the results suggest that the levels of both molecules are significantly decreased in the CSF in patients with PD compared with age-matched controls. Furthermore, specific detection and quantification of neurotoxic oligometric forms of \u03b1-synuclein in the blood using enzyme-linked immunosorbent assays might be expected as potential peripheral biomarkers for PD, although further validation is required. Currently, neither \u03b1-synuclein nor DJ-1 is satisfactory as a single biomarker for PD, but combinatory evaluation of these biological fluid molecules with other biomarkers and imaging techniques may provide reliable information for diagnosis of PD.<\/jats:p>","DOI":"10.3390\/ijms11114257","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T10:22:51Z","timestamp":1288693371000},"page":"4257-4266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["\u03b1-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"11","author":[{"given":"Masaaki","family":"Waragai","sequence":"first","affiliation":[{"name":"Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Sekiyama","sequence":"additional","affiliation":[{"name":"Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Sekigawa","sequence":"additional","affiliation":[{"name":"Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Takamatsu","sequence":"additional","affiliation":[{"name":"Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"key":"ref_1","first-page":"107","article-title":"Prostate cancer diagnosis","volume":"107","author":"Humphrey","year":"2010","journal-title":"Mo. Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1001\/jama.295.14.1688","article-title":"Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c","volume":"295","author":"Saudek","year":"2006","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Update on the biomarker core of the Alzheimer\u2019s Disease Neuroimaging Initiative subjects","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","article-title":"Midbrain iron content in early Parkinson disease: a potential biomarker of disease status","volume":"70","author":"Martin","year":"2008","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1212\/01.wnl.0000340982.01727.6e","article-title":"High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease","volume":"72","author":"Vaillancourt","year":"2009","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","article-title":"(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease","volume":"67","author":"Orimo","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","article-title":"Alpha-synuclein in Lewy body disease and Alzheimer\u2019s disease","volume":"9","author":"Hashimoto","year":"1999","journal-title":"Brain Pathol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.2009.06403.x","article-title":"Pathogenesis of familial Parkinson\u2019s disease: new insights based on monogenic forms of Parkinson\u2019s disease","volume":"111","author":"Hatano","year":"2009","journal-title":"J. Neurochem"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neurosci. Lett"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(98)00599-0","article-title":"The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson\u2019s disease or normal controls","volume":"253","author":"Jakowec","year":"1998","journal-title":"Neurosci. Lett"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci. Lett"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","article-title":"Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?","volume":"450","author":"Ohrfelt","year":"2009","journal-title":"Neurosci. Lett"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","article-title":"Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease","volume":"349","author":"Tokuda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"J. Neural Transm"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","article-title":"Plasma alpha-synuclein is decreased in subjects with Parkinson\u2019s disease","volume":"204","author":"Li","year":"2007","journal-title":"Exp. Neurol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","article-title":"Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson\u2019s disease, in erythropoietic lineage","volume":"358","author":"Nakai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1006\/bbrc.1997.6978","article-title":"NACP, a synaptic protein involved in Alzheimer\u2019s disease, is differentially regulated during megakaryocyte differentiation","volume":"237","author":"Hashimoto","year":"1997","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"Salem","year":"2006","journal-title":"FASEB J"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","article-title":"DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation withras","volume":"231","author":"Nagakubo","year":"1997","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_29","first-page":"456","article-title":"Function of DJ-1, a causative gene for familial Parkinson\u2019s disease","volume":"76","author":"Ariga","year":"2004","journal-title":"Seikagaku"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2009.08.003","article-title":"DJ-1 and prevention of oxidative stress in Parkinson\u2019s disease and other age-related disorders","volume":"47","author":"Kahle","year":"2009","journal-title":"Free Radic. Biol. Med"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.M509079200","article-title":"Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases","volume":"281","author":"Choi","year":"2006","journal-title":"J. Biol. Chem"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2006.05.011","article-title":"Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson\u2019s disease","volume":"345","author":"Waragai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","article-title":"Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson\u2019s disease","volume":"425","author":"Waragai","year":"2007","journal-title":"Neurosci. Lett"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2007.11.027","article-title":"Secretion of DJ-1 into the serum of patients with Parkinson\u2019s disease","volume":"431","author":"Maita","year":"2008","journal-title":"Neurosci. Lett"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2006.05.031","article-title":"Establishment of specific antibodies that recognize C106-oxidized DJ-1","volume":"404","author":"Ooe","year":"2006","journal-title":"Neurosci. Lett"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","article-title":"The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease","volume":"127","author":"Bandopadhyay","year":"2004","journal-title":"Brain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/nbdi.2002.0466","article-title":"Systemic increase of oxidative nucleic acid damage in Parkinson\u2019s disease and multiple system atrophy","volume":"9","author":"Kikuchi","year":"2002","journal-title":"Neurobiol. Dis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000154597.24838.6B","article-title":"Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease","volume":"64","author":"Sato","year":"2005","journal-title":"Neurology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mds.870120604","article-title":"The role of the immune system in neurodegenerative disorders","volume":"12","author":"McGeer","year":"1997","journal-title":"Mov. Disord"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jnnp.2009.175752","article-title":"Increased serum insulin-like growth factor 1 in early idiopathic Parkinson\u2019s disease","volume":"81","author":"Godau","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/11\/11\/4257\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:03:43Z","timestamp":1760220223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/11\/11\/4257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11]]}},"alternative-id":["ijms11114257"],"URL":"https:\/\/doi.org\/10.3390\/ijms11114257","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]}}}